Co-Authors
This is a "connection" page, showing publications co-authored by THOMAS W BURKE and CHERYL WALKER.
Connection Strength
0.332
-
Arzoxifene as therapy for endometrial cancer. Gynecol Oncol. 2003 Aug; 90(2 Pt 2):S40-6.
Score: 0.229
-
Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin Cancer Res. 2008 May 01; 14(9):2543-50.
Score: 0.080
-
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer. 2010 Dec 01; 116(23):5415-9.
Score: 0.023